• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性阿片系统研究在肥胖和饮食障碍的跨专业诊断和治疗中的整合。

Integration of Endogenous Opioid System Research in the Interprofessional Diagnosis and Treatment of Obesity and Eating Disorders.

机构信息

Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK.

Obesity and Eating Disorders Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico.

出版信息

Adv Neurobiol. 2024;35:357-380. doi: 10.1007/978-3-031-45493-6_18.

DOI:10.1007/978-3-031-45493-6_18
PMID:38874732
Abstract

This third and final chapter in our trilogy introduces the clinical distinctions and phenotypical similarities between obesity and eating disorders. Research elaborating on the shared neurobiological substrates for obesity and eating disorders is discussed. We present an interprofessional model of treatment for both disordered eating and for obesity. Additionally, this chapter establishes the translational importance of research connecting endogenous opioid activity with both obesity and eating disorders, with an emphasis on clinical interventions. We conclude with a discussion of future directions for research.

摘要

这是我们三部曲的第三也是最后一章,介绍了肥胖症和饮食失调之间的临床差异和表型相似之处。讨论了阐述肥胖症和饮食失调共同神经生物学基础的研究。我们提出了一种针对饮食失调和肥胖症的跨专业治疗模式。此外,本章还确立了将内源性阿片活性与肥胖症和饮食失调联系起来的研究的转化重要性,重点是临床干预。最后,我们讨论了未来的研究方向。

相似文献

1
Integration of Endogenous Opioid System Research in the Interprofessional Diagnosis and Treatment of Obesity and Eating Disorders.内源性阿片系统研究在肥胖和饮食障碍的跨专业诊断和治疗中的整合。
Adv Neurobiol. 2024;35:357-380. doi: 10.1007/978-3-031-45493-6_18.
2
Role of Endogenous Opioids in the Pathophysiology of Obesity and Eating Disorders.内源性阿片在肥胖和饮食失调的病理生理学中的作用。
Adv Neurobiol. 2024;35:329-356. doi: 10.1007/978-3-031-45493-6_17.
3
Endogenous Opioids in the Homeostatic Regulation of Hunger, Satiety, and Hedonic Eating: Neurobiological Foundations.内源性阿片肽在饥饿、饱腹感和享乐性进食的稳态调节中的作用:神经生物学基础。
Adv Neurobiol. 2024;35:315-327. doi: 10.1007/978-3-031-45493-6_16.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
An intensive weight loss programme with behavioural support for people with type 2 diabetes at risk of eating disorders in England (ARIADNE): a randomised, controlled, non-inferiority trial.英国针对有饮食失调风险的2型糖尿病患者开展的一项强化减肥计划及行为支持(ARIADNE):一项随机对照非劣效性试验。
Lancet Psychiatry. 2025 Jul;12(7):483-492. doi: 10.1016/S2215-0366(25)00126-9.
6
Prevalence and associated factors of eating disorders among metabolic bariatric surgery patients in Egypt.埃及代谢性减重手术患者中饮食失调的患病率及相关因素
J Eat Disord. 2025 Aug 25;13(1):182. doi: 10.1186/s40337-025-01373-0.
7
Systematic review and meta-analysis of the efficacy of interventions for people with Type 1 diabetes mellitus and disordered eating.1 型糖尿病伴饮食障碍患者干预措施疗效的系统评价和荟萃分析。
Diabet Med. 2017 Dec;34(12):1667-1675. doi: 10.1111/dme.13509. Epub 2017 Sep 26.
8
Interventions for preventing eating disorders in children and adolescents.预防儿童和青少年饮食失调的干预措施。
Cochrane Database Syst Rev. 2002;2002(2):CD002891. doi: 10.1002/14651858.CD002891.
9
Healthy eating interventions delivered in early childhood education and care settings for improving the diet of children aged six months to six years.在幼儿教育和照护环境中实施的健康饮食干预措施,以改善 6 个月至 6 岁儿童的饮食。
Cochrane Database Syst Rev. 2023 Aug 22;8(8):CD013862. doi: 10.1002/14651858.CD013862.pub3.
10
Obesity may be more associated with disordered eating behaviors, somatization, insecure attachment styles, and sexual dysfunction: an exploratory study.肥胖可能与饮食行为紊乱、躯体化、不安全依恋模式及性功能障碍关联更大:一项探索性研究。
J Sex Med. 2025 Aug 4;22(8):1465-1474. doi: 10.1093/jsxmed/qdaf133.

引用本文的文献

1
Association of Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders.饮食失调患者基因变异与体重变化及心理测量指标的关联
J Clin Med. 2024 Sep 1;13(17):5189. doi: 10.3390/jcm13175189.

本文引用的文献

1
Obesity in adults: a clinical practice guideline.成人肥胖:临床实践指南。
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
2
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.靶向内源性大麻素 CB1 受体治疗体重紊乱:过去和现在 CB1 药物治疗潜力的临床前和临床综述。
Biomolecules. 2020 Jun 4;10(6):855. doi: 10.3390/biom10060855.
3
Joint international consensus statement for ending stigma of obesity.《终止肥胖耻辱国际联合共识声明》
Nat Med. 2020 Apr;26(4):485-497. doi: 10.1038/s41591-020-0803-x. Epub 2020 Mar 4.
4
The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior.阿片类系统与食物摄入:阿片类拮抗剂在治疗暴饮暴食症和异常进食行为中的应用。
J Clin Med Res. 2020 Feb;12(2):41-63. doi: 10.14740/jocmr4066. Epub 2020 Feb 1.
5
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.肥胖与代谢外科医师协会、美国临床内分泌医师协会/美国内分泌学会、美国代谢与减重外科学会、美国肥胖医学协会和美国麻醉医师学会共同发布的《肥胖患者减重手术围手术期营养、代谢和非手术支持临床实践指南 2019 更新版》
Surg Obes Relat Dis. 2020 Feb;16(2):175-247. doi: 10.1016/j.soard.2019.10.025. Epub 2019 Oct 31.
6
Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: a Practical Guideline.术前和术后肥胖症患者的营养、身体活动和补充剂处方:实用指南。
Obes Surg. 2019 Oct;29(10):3385-3400. doi: 10.1007/s11695-019-04112-y.
7
Endogenous opioid modulation of food intake and body weight: Implications for opioid influences upon motivation and addiction.内源性阿片肽对摄食和体重的调节:对阿片肽影响动机和成瘾的启示。
Peptides. 2019 Jun;116:42-62. doi: 10.1016/j.peptides.2019.04.008. Epub 2019 Apr 30.
8
Obesity: global epidemiology and pathogenesis.肥胖症:全球流行病学和发病机制。
Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8.
9
The long-term effect of bariatric surgery on depression and anxiety.减重手术对抑郁和焦虑的长期影响。
J Affect Disord. 2019 Mar 1;246:886-894. doi: 10.1016/j.jad.2018.12.113. Epub 2018 Dec 28.
10
Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial.肥胖的强化行为治疗联合利拉鲁肽 3.0mg:一项随机对照试验。
Obesity (Silver Spring). 2019 Jan;27(1):75-86. doi: 10.1002/oby.22359. Epub 2018 Nov 13.